]i increases induced by T2 and T3. In the presence of extracellular calcium (1.2 mM), under carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, T2 and T3 increased both [Ca 2ϩ ]i and intracellular Na ϩ concentration; nimodipine reduced the [Ca 2ϩ ]i increases elicited by T2 and T3, but inhibition of NO synthase and blockade of the Na ϩ /H ϩ pump by 5-(N-ethyl-N-isopropyl)amiloride prevented only that elicited by T3; and CB-DMB, bisindolylmaleimide, and LY-294002 (inhibitors of the Na ϩ /Ca 2ϩ exchanger, PKC, and phosphatidylinositol 3-kinase, respectively) failed to modify the T2-and T3-induced effects. Collectively, the present results suggest that T2 and T3 exert short-term nongenomic effects on intracellular calcium and NO by modulating plasma membrane and mitochondrial pathways that differ between these iodothyronines. thyroid hormones; mitochondria; calcium; nitric oxide THYROID HORMONES (thyroxine, T4; triiodothyronine, T3) play important roles in cellular development, growth, and metabolism, mainly through the interaction of T3 with nuclear receptors (38). In addition, short-term, nongenomic actions of thyroid hormones have been reported to occur at the level of the plasma membrane, channels and pumps, cytoskeleton, cytoplasm, and organelles in mammalian cells (for review, see Ref. 16 and references therein) (15, 17, 33, 48, 51) . Some of these actions lead rapidly to posttranslational modifications of nucleoproteins, including MAPK-mediated serine phosphorylation of the thyroid hormone receptor (13), estrogen receptor (52), and p53 (49). In addition, upstream of MAPK, PKC and phosphatidylinositol 3-kinase (PI3-K) pathways may also be activated by thyroid hormones (42).
]i increase induced by T2 and T3. However, while depletion of inositol trisphosphate-dependent Ca 2ϩ stores did not interfere with the T2-and T3-induced [Ca 2ϩ ]i increases, the inhibition of phosphatidylinositol 3-kinase by LY-294002 and the dominant negative form of Akt mutated at the ATP binding site prevented these effects. Furthermore, the mitochondrial protonophore carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone prevented the increases in both [Ca 2ϩ ]i and NO elicited by T2 or T3. Interestingly, rotenone blocked the early [Ca 2ϩ ]i increases elicited by T2 and T3, while antimycin prevented only that elicited by T3. Inhibition of mitochondrial Na ϩ /Ca 2ϩ exchanger by CGP37157 significantly reduced the [Ca 2ϩ ]i increases induced by T2 and T3. In the presence of extracellular calcium (1.2 mM), under carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, T2 and T3 increased both [Ca 2ϩ ]i and intracellular Na ϩ concentration; nimodipine reduced the [Ca 2ϩ ]i increases elicited by T2 and T3, but inhibition of NO synthase and blockade of the Na ϩ /H ϩ pump by 5-(N-ethyl-N-isopropyl)amiloride prevented only that elicited by T3; and CB-DMB, bisindolylmaleimide, and LY-294002 (inhibitors of the Na ϩ /Ca 2ϩ exchanger, PKC, and phosphatidylinositol 3-kinase, respectively) failed to modify the T2-and T3-induced effects. Collectively, the present results suggest that T2 and T3 exert short-term nongenomic effects on intracellular calcium and NO by modulating plasma membrane and mitochondrial pathways that differ between these iodothyronines. thyroid hormones; mitochondria; calcium; nitric oxide THYROID HORMONES (thyroxine, T4; triiodothyronine, T3) play important roles in cellular development, growth, and metabolism, mainly through the interaction of T3 with nuclear receptors (38) . In addition, short-term, nongenomic actions of thyroid hormones have been reported to occur at the level of the plasma membrane, channels and pumps, cytoskeleton, cytoplasm, and organelles in mammalian cells (for review, see Ref. 16 and references therein) (15, 17, 33, 48, 51) . Some of these actions lead rapidly to posttranslational modifications of nucleoproteins, including MAPK-mediated serine phosphorylation of the thyroid hormone receptor (13) , estrogen receptor (52) , and p53 (49) . In addition, upstream of MAPK, PKC and phosphatidylinositol 3-kinase (PI3-K) pathways may also be activated by thyroid hormones (42) .
These rapid events seem to imply the existence of membrane receptors for thyroid hormones linked to signal-transduction pathways that are not yet well characterized. Indeed, membrane binding sites for T3 have been identified in human and rat erythrocytes (9, 2), rat hepatocytes (28, 40) , and pituitary cells (25) , and Bergh and colleagues (7) have identified integrin-␣V␤3 as a plasma membrane thyroid hormone binding site.
In addition to T3, other iodothyronines, such as 3,5-diiodo-L-thyronine (T2), a naturally occurring iodothyronine, display biological activities. Indeed, it has been shown that T2 exerts short-term effects on both resting metabolic rate and mitochondrial activities (29) , essentially by a nuclearindependent pathway (for review, see Ref. 35 and references therein). In previous studies, it has been suggested that T2, as well as T3, may influence cellular energy metabolism and cell differentiation by modulating ion pathways (27, 36, 47) . In particular, T3 can induce a redistribution of calcium across plasma and mitochondrial membranes, thereby affecting energy metabolism (27, 36) . Although a role for calcium has been proposed in the mediation of the nongenomic effects triggered by iodothyronines, the underlying biochemical pathways are not yet fully established.
In the present study, in pituitary GH 3 cells, we explored 1) the modulating effects of T2 and T3 on the intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ); and 2) the cellular/molecular mechanisms that might mediate these effects. A particular feature of GH 3 cells is the occurrence of [Ca 2ϩ ] i oscillations (43), a phenomenon involved both in growth hormone and prolactin release by somato-mammotrophs (50) and in gene expression (8, 12, 26, 32, 53) . In addition, T2 has been reported to increase type 1 5=deiodinase activity in these cells (6) . Two main pathways take part in the mechanism underlying [Ca 2ϩ ] i oscillations in pituitary cells: an intracellular and a plasma membrane one (50) . The first comprises the ryanodine-and inositol trisphosphate (IP 3 )-sensitive intracellular Ca 2ϩ stores and their refilling channels, whereas the second relies on the concerted activity of different classes of plasma membrane ion channels, such as Na ϩ , Ca 2ϩ , and K ϩ channels (43, 50) . Intriguingly, the ion channels involved in the complex genesis of [Ca 2ϩ ] i oscillations are regulated by nitric oxide (NO), which is itself able to trigger this electrical phenomenon in GH 3 cells (3, 45) . Since mitochondria are crucial in the regulation of cytosolic Ca 2ϩ signaling, in this study we also investigated the role of these organelles in the modulation of cytosolic Ca 2ϩ homeostasis by thyroid hormones.
The results of the present study suggest that Ca 2ϩ and NO act as mediators of the rapid, nongenomic effects of T2 and T3, and that underlying these effects are modulations of molecular mechanisms at both the plasma membrane and mitochondrial level that differ between T2 and T3.
MATERIAL AND METHODS
Drugs and chemicals. Fura 2-acetoxymethyl ester (AM), thapsigargin (Tg), N G -nitro-L-arginine methyl ester (L-NAME), and antimycin were obtained from Calbiochem (La Jolla, CA), while CGP was from Tocris. All other chemicals were from Sigma (St. Louis, MO). L-NAME and L-arginine were dissolved at the appropriate concentration immediately before each experiment. Stock solutions of the other chemicals were prepared in DMSO and kept at Ϫ20°C. Appropriate dilutions were prepared daily. Cell culture, cloning, and transfection. GH3 cells were obtained from Flow Laboratories (Irvine, UK) and grown on plastic dishes in Ham's F10 medium (Gibco, Invitrogen) supplemented with 15% horse serum (Flow Laboratories), 2.5% fetal calf serum (Hyclone, Logan, UT), 100 U/ml penicillin, and 100 g/ml streptomycin. The cells were cultured in a humidified 5% CO2 atmosphere, and the culture medium was changed every 2 days. For microfluorimetric studies, cells were plated on glass coverslips (Fisher, Springfield, NJ) coated with poly-L-lysine (10 g/ml) (Sigma) and used at least 12-16 h after seeding. The dominant-negative form of Akt (AktϪ) has been mutated at the ATP binding site, and it results in an inactive kinase (20 ]i was measured by single-cell, computer-assisted video imaging. Briefly, GH 3 cells, grown on glass coverslips, were loaded with 6 M fura 2-AM for 30 min at 37°C in normal Krebs solution containing the following (in mM: 5.5 KCl, 160 NaCl, 1.2 MgCl2, 1.5 CaCl2, 10 glucose, and 10 HEPES-NaOH, pH 7.4). At the end of the fura 2-AM loading period, the coverslips were placed in a perfusion chamber (Medical System, Greenvale, NY) mounted on the stage of a Zeiss Axiovert 200 microscope (Carl Zeiss) equipped with a FLUAR 40ϫ oil objective lens. The experiments were carried out using a digital imaging system comprising a MicroMax 512BFT cooled charge-coupled device camera (Princeton Instruments, Trenton, NJ), a LAMBDA 10 -2 filter wheeler (Sutter Instruments, Novato, CA), and Meta-Morph/MetaFluor Imaging System software (Universal Imaging, West Chester, PA). After loading, cells were alternately illuminated with light of 340-nm and 380-nm wavelengths emitted from a xenon lamp. The emitted light was passed through a 512-nm barrier filter. Fura 2 fluorescence intensity was measured every 1 s during the detection of [Ca 2ϩ ]i oscillations and every 3 s for all other experiments.
Intracellular Na ϩ levels were determined, using the integrated system described above, by loading the cells with 15 M sodiumbinding benzofuran isophthalate at room temperature for 150-to 180-min incubation in the presence of 0.125% Pluronic F-127 (Invitrogen, Karlsruhe, Germany). Fluorescence images were acquired at excitation wavelengths of 340 nm and 360 nm every 3 s. Sodium levels are expressed as fluorescence ratios (F 340/F360). [Ca 2ϩ ]i oscillations were identified, and their amplitude and frequency determined, using a computer program written in Java language, as previously described in detail (45) . Briefly, for each single cell, the software ]i oscillations, these values were used to define a cutoff, which was set at the mean [Ca 2ϩ ]i Ϯ 2 SD. Then the oscillation frequency was calculated as previously reported (45) .
To evaluate the effects of drugs on the pattern of spontaneous [Ca 2ϩ ]i oscillations, we compared mean oscillation frequency recorded before (i.e., internal control) and during treatment. In control experiments, no significant changes in either frequency or amplitude occurred after addition of drug vehicles. NO detection by 4,5-diaminofluorescein-2 assay. Cells were loaded with 10 M 4,5-diaminofluorescein-2-diacetate in normal Krebs solution (5.5 mM KCl, 160 mM NaCl, 1.2 mM MgCl 2, 1.5 mM CaCl2, 10 mM glucose, and 10 mM HEPES-NaOH, pH 7.4) in the presence of a given drug (at 37°C for 20 min). For control experiments, cells were incubated only in normal Krebs solution containing a drug vehicle (at 37°C for 20 min). Subsequently, fluorescent cells were fixed using 4% (wt/vol) paraformaldehyde in PBS for 5 min at 4°C. This procedure permits subsequent densitometric analysis, with the fluorescence microscope (Nikon Eclipse E400; Nikon, Torrance, CA) set at excitation/emission wavelengths of 495/515 nm. Then fluorescent images are stored and analyzed using Pro-Plus software (Media Cybernetics, Silver Spring, MD). The data are reported as a percentage of the fluorescence detected in the control group.
Statistical analysis of the data. Data are reported as means Ϯ SE. Statistical analysis was performed using either a paired Student's t-test or ANOVA followed by the Newman-Keuls post hoc test for unpaired data, as appropriate. [Ca 2ϩ ] i . In line with our laboratory's previous results (43, 45) , the majority of pituitary GH 3 cells showed significant [Ca 2ϩ ] i oscillations over time, while ϳ30% were quiescent (Fig. 1) . The oscillatory pattern was dependent on extracellular Ca 2ϩ , since it was abolished when extracellular Ca 2ϩ was removed (1 mM EGTA, Ca 2ϩ free) (Fig. 1B) .
RESULTS

Effects of T2 and T3 on
To determine whether T2 and/or T3 regulates Ca 2ϩ homeostasis in GH 3 ] i elevation (Fig. 2, A and B) . The mean oscillation frequency increased from 1.0 Ϯ 0.3 to 7.2 Ϯ 1 Hz (P Ͻ 0.05) upon T2 addition and from 1.0 Ϯ 0.3 to 3.2 Ϯ 0.5 Hz (P Ͻ 0.01) upon T3 addition (Fig. 2C) . Drug vehicle failed to modify the oscillatory pattern of GH 3 cells (Fig. 2A) .
Role (Fig. 3, A and D) in a dosedependent way (Fig. 3, G and H) , suggesting that their effects were dependent on Ca 2ϩ release from intracellular compartments. (Fig. 3, B , E, and G), indicating a crucial role for an "early" production of NO in mediating the Ca 2ϩ release from intracellular compartments. This effect was mimicked by L-N 5 -(1-iminoethyl)ornithine hydrochloride, a specific inhibitor of neuronal NOS (Fig.  3, C, F, and G) , the only isoform highly expressed in GH 3 cells (44) .
To dissect out the contribution of IP 3 -dependent stores in the T2-and T3-induced effects, we studied the consequences of selective depletion of these stores. To that end, we stimulated cells using ATP plus the specific sarcoplasmic-endoplasmic reticulum (ER) Ca 2ϩ -ATPase inhibitor Tg or ATP alone in the absence of extracellular calcium. In these experimental conditions, the [Ca 2ϩ ] i elevations induced by exposure to T2 and T3 were unchanged (Fig. 4, A and B -free solution were significantly reduced when PI3-K/Akt pathway was blocked using the well-known PI3-K inhibitor 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY-294002) (Fig. 4C) . Accordingly, the overexpression of the Akt inactive form (AktϪ) in GH 3 cells significantly reduced the [Ca 2ϩ ] i increases elicited by T2 and T3 in Ca 2ϩ -free solution (Fig. 4C) . ] i seen previously (e.g., Fig. 3 ) when T2 or T3 was applied in Ca 2ϩ -free solution (Fig. 5, A and B) . Verification of cell responsiveness in those experiments was obtained using ionomycin (Fig. 5A) . On the other hand, FCCP, as well as ATP plus Tg, failed to prevent the rapid rise in [Ca 2ϩ ] i induced by T1, another iodothyronine able to modulate intracellular Ca 2ϩ homeostasis in GH 3 cells (Fig. 6) .
Role of mitochondrial pathways in T2-, T3-, and T1-induced
In parallel experiments, we observed that T2 and T3, but not T1, induced delayed increases in 4,5-diaminofluorescein-2-monitored NO (latency to onset ϳ1 s), thus mimicking the effect of the NO precursor L-arginine (10 mM) (Fig. 7A) . Interestingly, upon addition of T2 and T3, increases in NO levels were also observed in the absence of extracellular Ca 2ϩ (Fig. 7B) . Pretreatment with ATP plus Tg was ineffective at preventing the effects on NO induced by T2 or T3 in Ca 2ϩ -free solution (Fig. 7C) . In contrast, preincubation with FCCP largely prevented these effects (Fig. 7D) , suggesting a key role for intact mitochondria in this delayed NO generation. Although rotenone, a specific mitochondrial complex I inhibitor, greatly reduced the early increases in [Ca 2ϩ ] i induced by both T2 and T3 (Fig. 8) , antimycine, a specific inhibitor of complex III, largely prevented the early increase in [Ca 2ϩ ] i induced by T3 without affecting that induced by T2 (Fig. 9 ). This demonstrates a difference in mitochondrial targeting between T2 and T3. Furthermore, blockade of the major Ca 2ϩ -extruding system at the mitochondrial level [namely, the mitochondrial Na ϩ /Ca 2ϩ exchanger (mtNCX)] by CGP37157 almost completely prevented the early increase in [Ca 2ϩ ] i elicited by addition of either T2 or T3 in Ca 2ϩ -free solution (Fig. 10) . ] i (Fig. 11, A and B) . To identify the molecular transducers of the extracellular component responsible for the depolarizing effects of T2 and T3, we pharmacologically modulated several Na (Fig. 11A) . Likewise, preincubation with EIPA largely prevented [Ca 2ϩ ] i being increased by T3, but not by T2, in cells pretreated with FCCP (Fig. 11B) . Under the same conditions, nimodipine, a selective blocker of L-type voltage-dependent Ca 2ϩ channels (VDCC), reduced the early increase in [Ca 2ϩ ] i induced by either T2 or T3 (Fig. 11B) ] i elevation induced by T2 or T3 (Fig. 11B) . To test whether the plasma-membrane targets of T2 and T3 might be modulated by the PKC/Akt-dependent signaling cascade, we evaluated (in the above conditions) the effects of bisindolylmaleimide and LY-294002, selective blockers of PKC and PI3-K, respectively. Neither blocker modified the T2-or T3-induced increase in [Ca 2ϩ ] i in cells pretreated with FCCP (Fig. 11C) ] i , whether elicited by T3 or T2, was dependent on both extracellular and intracellular pathways. In particular, our data showed that, within the intracellular compartment, mitochondria, but not IP 3 -dependent stores, was involved in the rapid increase in [Ca 2ϩ ] i, when it was elicited by T2 or T3. In contrast, T1 produced an early increase in [Ca 2ϩ ] i that was independent from mitochondrial pathways. Furthermore, the exposure to either T2 or T3 induced an early production of NO that triggers a rapid [Ca 2ϩ ] i increase, as well as a delayed one that is most likely associated with their downstream effects. In contrast, T1 does not induce delayed NO production. Moreover, it is possible to hypothesize that a small and rapid influx of [Ca 2ϩ ] i induced by both T2 and T3 could promote a production of NO that, in turn, determined a more sustained increase in [Ca 2ϩ ] i , associated with a mitochondrial depletion through mtNCX. Furthermore, the delayed production of the gaseous mediator induced by the iodothyronines was dependent only on mitochondrial activity and could be considered as a result of sustained [Ca 2ϩ ] i increase. In light of this evidence, NO could be considered as an amplifying messenger of the rapid and delayed cellular effects of the two iodothyronines. This is in line with previous report suggesting that NO can modulate mitochondrial signaling (18) .
Pharmacological modulation of ion transporters and channels involved in T2-and T3-induced increases in [Ca
To our knowledge, this is the first evidence of the role of NO in the effects exerted by T3 and T2 over [Ca 2ϩ ] i homeostasis (see Fig. 12 ).
Our finding that the depletion of IP 3 stores did not modify the T2-and T3-induced rapid increases in [Ca 2ϩ ] i does not rule out the possibility that these Ca 2ϩ stores might be involved in the mechanism of action of these two iodothyronines, as already shown in other systems (28) . For instance, the IP 3 -dependent release of [Ca 2ϩ ] i from ER could be involved in the maintenance over time of [Ca 2ϩ ] i oscillations, as normally occurs in spontaneously oscillating GH 3 cells (45) . In addition, it is possible that cross talk takes place between mitochondria and ER, as suggested in the responses to several receptor agonists. Indeed, there is both structural and functional evidence suggesting that mitochondria and ER are closely coupled in the handling of Ca 2ϩ levels, probably through specific and stable interactions (19, 24, 41) .
In this study, both the depletion of mitochondrial calcium and the inhibition of mitochondrial complex I completely prevented the rise in [Ca 2ϩ ] i induced by T2 and T3, respectively, thus suggesting that these two phenomena are possibly linked. The inhibition of complex III, on the other hand, reduced only the effect induced by T3; hence the mitochondrial targeting differ somewhat between T2 and T3. Interestingly, intracellular Ca 2ϩ homeostasis is involved in short-term stimulation of mitochondrial metabolism, either by T2 or by T3 (27) . However, the question concerning the molecular basis underlying T2 and T3 stimulatory action at the level of mitochondrial metabolism through Ca-signaling is still open. It seems now accepted that some effects elicited by both T2 and T3 at the mitochondrial level are not mediated by canonical thyroid hormone receptors (22) , and some specific binding sites for both T2 and T3 have been shown in mitochondria (5, 56) . Consequently, it is conceivable that these effects may be due to a direct interaction with the organelle. However, we cannot exclude, on the basis of the present results, that mitochondrial complexes I and III might constitute new "direct targets" for mediating such rapid effects of these molecules. Mitochondria are known to be a physiological Ca 2ϩ reservoir (4, 30) , since their large capacity and rate of Ca 2ϩ accumulation allow them temporarily to take up most of the Ca 2ϩ released intracellularly during cell stimulation (31) . Thus, by serving as a Ca 2ϩ -buffering system, mitochondria modulate the amplitude of the cytosolic Ca 2ϩ transient, and thereby regulate several physiological phenomena (14, 21, 34, 55) . The subsequent, slower release of the accumulated Ca 2ϩ generates a characteristic shoulder in a number of stimulus-induced [Ca 2ϩ ] i transients (54) and also facilitates Ca 2ϩ refilling of the ER (23) . In our study, the effects of T2 and T3 on [Ca 2ϩ ] i increases were prevented by inhibiting the mtNCX in a pharmacological way, thus suggesting that this exchanger constitutes an important molecular target at mitochondrial level. Concerning the regulation of mtNCX by the two iodothyronines, it could occur directly or, alternatively, in indirect way. Indeed, the increase in cytosolic Na ϩ level, which we detected in our model, may promote Ca 2ϩ efflux from the organelle by mtNCX (57) . Furthermore, it has been reported that mitochondrial membrane potential dissipation does not affect Ca 2ϩ efflux from mitochondria through mtNCX, especially at higher [Ca 2ϩ ] i (37), a condition normally occurring in oscillating GH 3 (43, 45 ] i increases elicited by T2 and T3 suggests that these two iodothyronines share L-type VDCC as a plasma-membrane target. In this regard, we postulate that such L-type VDCC activation may result either from a direct interaction with the channel or through Na ϩ -dependent depolarization, allowing T2 and T3 to interfere differentially with the above-mentioned mechanism (see Fig. 12 ). A previous report revealed that, in rat neonatal atrial myocytes, T3 has no direct effect on L-type Ca 2ϩ channels, but increases Na ϩ /Ca 2ϩ exchanger density currents (17) . However, our study strongly suggests that in GH 3 cells, the plasma-membrane Na ϩ /Ca 2ϩ exchanger is not involved in the [Ca 2ϩ ] i increases induced by T2 and T3 since CB-DMB, the most potent inhibitor of that exchanger (46) , did not block their effects. Furthermore, L-NAME prevented only T3-induced but not T2-induced [Ca 2ϩ ] i elevation when the "intracellular compartment" was excluded by FCCP. This findings suggest that, in GH 3 cells, although the regulatory effects of both T2 and T3 on intracellular pathways are mediated by NO, this mediator is involved only in the modulation of plasma membrane pathways induced by T3, not in that induced by T2 that might act directly. Moreover, the effect of T3 on extracellular calcium influx could be dependent, on either NO by itself or such NO-dependent mediator (i.e., cGMP?). For instance, it has been shown that L-type VDCCs could be modulated by NO in a direct or indirect way (10) . Similarly, in erythrocytes, the membrane-permeable analog dibutyryl cGMP can modulate the Na ϩ /H ϩ exchange (39), which is activated by T3 in the present experimental conditions.
Concerning the transduction of the effects elicited by T2 and T3, our data indicate that the PI3-K/Akt pathway is involved in the rapid effects (ϳ1 min) mediated by intracellular mechanisms, but not in those mediated by plasma membrane ones. This is not inconsistent with earlier results (42), since our data do not rule out a secondary, slow modulation of the plasmamembrane targets via the PI3-K/Akt pathway.
Furthermore, the effects of T2 or T3 in modulating [Ca 2ϩ ] i elevation in pituitary cells are clearly different from those observed with T1. Although all of the iodothyronines tested elicited Ca 2ϩ influx through plasma membrane mechanisms, mitochondrial complexes and mtNCX were directly modulated only by T2 and T3, but not by T1. Interestingly, despite T2 or T3, T1 did not interfere with mitochondrial activity and failed to induce a delayed NO production.
Collectively, our study demonstrates the following: 1) T2 and T3 each induced an increase in [Ca 2ϩ ] i accompanied by NO release; 2) the observed effects of T2 and T3, were dependent on both extracellular and intracellular calcium; 3) NO was involved in the effects of both T2 and T3 on [Ca 2ϩ ] i ; 4) mitochondria play critical roles in the induced calcium elevations, but the precise mechanisms differ between T2 and T3; 4) T2 and T3 each facilitate physiological Ca 2ϩ efflux from mitochondria through activation of mt-NCX, but as a consequence of interaction with different mitochondrial complexes (Fig. 12) . Thus our data reveal that, although T2 and T3 each modulate [Ca 2ϩ ] i handling in pituitary GH 3 cells by targeting mitochondrial and plasma membrane proteins, the precise mechanism of action differs between these iodothyronines and is related to their individual abilities to modulate specific targets. 
